Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report

Aspirin / Clopidogrel

Data on age, BMI, diabetes duration, gender, initial visit, indigenous status, currently pregnant individuals, smoking status and type of diabetes by treatment

Page last updated: December 2011

Amongst Adults where data were provided, results were similar to those provided in 2006 and 2009 with 44.0% reported to be on Aspirin [51.5% No; 4.5% Contraindicated], and 8.2% reported to be on Clopidogrel [89.2% No; 2.6% Contraindicated], & 4.2% reportedly on both.

Aspirin
n = 3631
Yes
No
Contraindicated
Both
2011
44.0%
51.5%
4.5%
4.2%
2009
50.9%
43.2%
5.9%
4.0%
2006
42.9%
47.1%
10.0%
2.8%
Clopidogrel
n = 3818
Yes
No
Contraindicated
Both
2011
8.2%
89.2%
2.6%
4.2%
2009
7.7%
87.8%
4.6%
4.0%
2006
8.7%
83.7%
7.6%
2.8%
[Also see Tables on pp 185-188 Appendix 5]

Document download

This publication is available as a downloadable document.

Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report(PDF 559 KB)